A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours

O. A. Khan, M. Gore, P. Lorigan, J. Stone, A. Greystoke, W. Burke, J. Carmichael, A. J. Watson, G. McGown, M. Thorncroft, G. P. Margison, R. Califano, J. Larkin, S. Wellman, M. R. Middleton

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science